124 related articles for article (PubMed ID: 23879002)
1. [Comparison of the prevalence frequency of infectious skin changes in dialyzed patients and after kidney transplantation].
Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuźniewski M; Sułowicz W
Przegl Lek; 2013; 70(2):41-7. PubMed ID: 23879002
[TBL] [Abstract][Full Text] [Related]
2. [Factors influencing on the prevalence frequency of infectious skin changes of bacterial and fungal origin in patients after kidney transplantation].
Sułowicz J; Wojas-Pelc A; Kuzniewski M; Ignacak E; Betkowska-Prokop A; Sułowicz W
Przegl Lek; 2013; 70(7):431-6. PubMed ID: 24167942
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors of non melanoma skin cancers in kidney transplant patients].
Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous viral infections in patients after kidney transplantation: risk factors.
Sułowicz J; Wojas-Pelc A; Kuźniewski M; Ignacak E; Janda K; Sułowicz W
Pol Arch Med Wewn; 2013; 123(12):686-92. PubMed ID: 24240986
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of immunosuppressive treatment on homocystein levels in patients after kidney transplantation during a 2 year observation period].
Aksamit D; Janda K; Kuźniewski M; Krzanowski M; Ignacak E; Betkowska-Prokop A; Chowaniec E; Sułowicz W
Przegl Lek; 2012; 69(11):1175-9. PubMed ID: 23646442
[TBL] [Abstract][Full Text] [Related]
7. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
8. Skin tumors and skin infections in kidney transplant recipients vs. patients with pemphigus vulgaris.
Sharquie KE; Noaimi AA; Al-Jobori AA
Int J Dermatol; 2014 Mar; 53(3):288-93. PubMed ID: 23968536
[TBL] [Abstract][Full Text] [Related]
9. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
10. Skin infections in 401 renal transplant recipients in southern Turkey.
Dicle O; Parmaksizoglu B; Gurkan A; Tuncer M; Demirbas A; Yilmaz E
Exp Clin Transplant; 2009 Jun; 7(2):133-6. PubMed ID: 19715520
[TBL] [Abstract][Full Text] [Related]
11. The pattern of mucocutaneous infections and infestations in renal transplant recipients.
Sandhu K; Gupta S; Kumar B; Dhandha R; Udigiri NK; Minz M
J Dermatol; 2003 Aug; 30(8):590-5. PubMed ID: 12928527
[TBL] [Abstract][Full Text] [Related]
12. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
14. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
Bunnapradist S; Daswani A; Takemoto SK
Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
[TBL] [Abstract][Full Text] [Related]
15. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis.
Zhao YJ; Wen JQ; Cheng K; Ming YZ; She XG; Liu H; Liu L; Ye QF; Ding BN
Transplant Proc; 2013; 45(6):2226-32. PubMed ID: 23953533
[TBL] [Abstract][Full Text] [Related]
16. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
17. Mucocutaneous lesions in transplant recipient in a tropical country.
Prakash J; Singh S; Prashant GK; Kar B; Tripathi K; Singh PB
Transplant Proc; 2004 Sep; 36(7):2162-4. PubMed ID: 15518786
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment.
Chugh KS; Sharma SC; Singh V; Sakhuja V; Jha V; Gupta KL
Dermatology; 1994; 188(2):108-12. PubMed ID: 8136535
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
